Pulmonary Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older who live in Tampere or a nearby area in Finland
- People whose pulmonary arterial hypertension (a heart and lung condition) is classified as moderate in severity — specifically WHO functional class II or III (confirm with trial site)
- People who are willing and able to commit to taking part in an exercise program
- People whose condition has been stable, with no changes to their pulmonary arterial hypertension medications in the two months before joining
- People who have not had any fainting episodes or irregular heart rhythms causing symptoms in the two months before joining
Who may not be able to join:
- People with severe lung disease or a type of heart failure where the heart's main pumping chamber is significantly weakened
- People who are pregnant
- People with a severe type of congenital (present from birth) heart defect known as Eisenmenger syndrome
- People with severe liver disease
- People with an active, acute inflammatory condition (such as a serious infection or flare-up)
- People with severely low red blood cell levels (severe anaemia, based on a specific blood test result)
- People whose resting blood pressure is very low (systolic pressure below 85 mmHg)
- People who have had a recent fainting episode
- People with other significant health conditions that seriously affect their ability to be physically active, such as severe neurological diseases or major musculoskeletal problems
- People with serious irregular heart rhythms that have not been treated
- People whose pulmonary arterial hypertension medications are changed at any point during the rehabilitation program
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jussi A Hernesniemi, MD PhD, Tampere Heart Hospital
Phone: +3583311611
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in six-minute walking test result
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.